Total abdominal hysterectomy Surgery Hysterectomy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. American Society of Anaesthesiologists (ASA) class I - III 2. Patients able to give written informed consent 3. Patients requiring total abdominal hysterectomy 4. Female patients aged 18 years and over
Exclusion criteria
Exclusion criteria: 1. Patients requiring total abdominal hysterectomy secondary to neoplasia 2. History of allergy to any of the medications used in the study 3. Pre-operative use of opiates 4. Patients unable to use patient controlled analgesia system
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The reduction in visual analogue scores (VAS) in the post-operative period for patients undergoing total abdominal hysterectomy. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Usage of morphine sulphate in the post-operative period 2. Incidence of nausea and/or vomiting within the first 48 hours after surgery 3. Measurement of oxygen saturations without supplemental oxygen in both groups in the post-operative period 4. Incidence of complications associated with the analgesia techniques in both groups 5. Patient satisfaction with analgesia technique 6. Incidence of chronic pelvic pain at 3 months | — |
Countries
United Kingdom